Stay updated on Pembrolizumab in Elderly Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Elderly Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study page now shows 'No longer looking for participants' and adds new sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', while removing the old 'Intervention / Treatment' heading and the prior 'Revision: v3.5.5' note.SummaryDifference0.4%

- Check17 days agoChange DetectedThe page's revision indicator updated from Revision: v3.5.4 to Revision: v3.5.5, signaling a minor page refresh.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a minor backend/metadata update to the page. It does not change the core study information presented.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a site revision without changing the underlying study information.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Elderly Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.